Literature DB >> 29939458

KinITC-One Method Supports both Thermodynamic and Kinetic SARs as Exemplified on FimH Antagonists.

Pascal Zihlmann1, Marleen Silbermann1, Timothy Sharpe2, Xiaohua Jiang1, Tobias Mühlethaler1, Roman P Jakob3, Said Rabbani1, Christoph P Sager1, Priska Frei1, Lijuan Pang1, Timm Maier3, Beat Ernst1.   

Abstract

Affinity data, such as dissociation constants (KD ) or inhibitory concentrations (IC50 ), are widely used in drug discovery. However, these parameters describe an equilibrium state, which is often not established in vivo due to pharmacokinetic effects and they are therefore not necessarily sufficient for evaluating drug efficacy. More accurate indicators for pharmacological activity are the kinetics of binding processes, as they shed light on the rate of formation of protein-ligand complexes and their half-life. Nonetheless, although highly desirable for medicinal chemistry programs, studies on structure-kinetic relationships (SKR) are still rare. With the recently introduced analytical tool kinITC this situation may change, since not only thermodynamic but also kinetic information of the binding process can be deduced from isothermal titration calorimetry (ITC) experiments. Using kinITC, ITC data of 29 mannosides binding to the bacterial adhesin FimH were re-analyzed to make their binding kinetics accessible. To validate these kinetic data, surface plasmon resonance (SPR) experiments were conducted. The kinetic analysis by kinITC revealed that the nanomolar affinities of the FimH antagonists arise from both (i) an optimized interaction between protein and ligand in the bound state (reduced off-rate constant koff ) and (ii) a stabilization of the transition state or a destabilization of the unbound state (increased on-rate constant kon ). Based on congeneric ligand modifications and structural input from co-crystal structures, a strong relationship between the formed hydrogen-bond network and koff could be concluded, whereas electrostatic interactions and conformational restrictions upon binding were found to have mainly an impact on kon .
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  analytical methods; calorimetry; kinetics; method validation of kinITC; thermodynamics

Mesh:

Substances:

Year:  2018        PMID: 29939458     DOI: 10.1002/chem.201802599

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  5 in total

1.  Recombinant FimH Adhesin Demonstrates How the Allosteric Catch Bond Mechanism Can Support Fast and Strong Bacterial Attachment in the Absence of Shear.

Authors:  Wendy E Thomas; Laura Carlucci; Olga Yakovenko; Gianluca Interlandi; Isolde Le Trong; Pavel Aprikian; Pearl Magala; Lydia Larson; Yulia Sledneva; Veronika Tchesnokova; Ronald E Stenkamp; Evgeni V Sokurenko
Journal:  J Mol Biol       Date:  2022-06-11       Impact factor: 6.151

2.  RMSD analysis of structures of the bacterial protein FimH identifies five conformations of its lectin domain.

Authors:  Pearl Magala; Rachel E Klevit; Wendy E Thomas; Evgeni V Sokurenko; Ronald E Stenkamp
Journal:  Proteins       Date:  2019-11-05

Review 3.  An update of label-free protein target identification methods for natural active products.

Authors:  Zhao Cui; Caifeng Li; Peng Chen; Hongjun Yang
Journal:  Theranostics       Date:  2022-01-24       Impact factor: 11.556

4.  The Influence of Varying Fluorination Patterns on the Thermodynamics and Kinetics of Benzenesulfonamide Binding to Human Carbonic Anhydrase II.

Authors:  Steffen Glöckner; Khang Ngo; Björn Wagner; Andreas Heine; Gerhard Klebe
Journal:  Biomolecules       Date:  2020-03-27

5.  Calorimetric Analysis of the Interplay between Synthetic Tn Antigen-Presenting MUC1 Glycopeptides and Human Macrophage Galactose-Type Lectin.

Authors:  Donella M Beckwith; Forrest G FitzGerald; Maria C Rodriguez Benavente; Elizabeth R Mercer; Anna-Kristin Ludwig; Malwina Michalak; Herbert Kaltner; Jürgen Kopitz; Hans-Joachim Gabius; Maré Cudic
Journal:  Biochemistry       Date:  2021-02-09       Impact factor: 3.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.